CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
14197-60-5 | 人参皂苷rg3; 人参皂甙rg3 | Ginsenoside rg3; (3beta,12beta)-12,20-Dihydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; 20(S)-Ginsenoside-rg3 | C42H72O13 | 详情 | 供应商 | |
38243-03-7 | 人参皂苷rg3; 人参皂甙rg3 | Ginsenoside rg3; beta-D-Glucopyranoside,(3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl; 20(R)-Propanaxadiol | C42H72O13 | 详情 | 供应商 | |
84313-44-0 | L-Phenylalaninamide,L-phenylalanyl-L-methionyl-D-arginyl-; PHENYL-METHIONINE-D-ARGININE-PHENYL AMIDE); H-Phe-Met-D-Arg-Phe-NH2; neuropeptide C [D-Arg3]; [D-Arg3]-Molluscan cardioexcitatory neuropeptide; Phe-Met-D-Arg-Phe amide | C29H42N8O4S | 详情 | 供应商 | ||
125093-93-8 | VIP ANTAGONIST | H-LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SE; H-LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2; KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2; VASOACTIVE INTESTINAL PEPTIDE ANTAGONIST; VIP ANTAGONIST; (lys1,pro2,5,arg3,4,tyr6)-vasoactive*intestinal P; (LYS1 PRO2 5 Arg3 4 TYR6)-VASOACTIVE &; (VIP-neurotensin) hybrid antagonist; H-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | C154H257N49O40S | 详情 | 供应商 | |
115074-43-6 | 莫匹罗星钙(二水合物) | MUPIROCIN CALCIUM, REFERENCE SPECTRUM EP STANDARD; MUPIROCIN CALCIUM, REFERENCE SPECTRUM EP STANDARD; Calcium mupirocin dihydrate; L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-, 8-carboxyoctyl ester, calcium salt (2:1), dihydrate, [2E,8[2S,3S(1S,2S)]]- (9CI); mupirocin calcium hydrate; Calcium 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate dihydrate; Mupirocin calcium dihydrate; Unii-rg38I2p540 | C52H86CaO18 | 详情 | 供应商 |